Table 1.
Baseline characteristics of study participants with and without prevalent atrial fibrillation at baseline examination
| All subjects n=1694 | Subjects without prevalent AF n=1599 | Subjects with prevalent AF n=95 | P value | |
| Age (years) | 67.5 (±6.0) | 67.3 (±6.0) | 70.4 (±5.6) | <0.001 |
| Sex (n female (%)) | 502 (29.6) | 475 (29.7) | 27 (28.4) | 0.870 |
| Smoking (n (%)) | 298 (17.6) | 287 (17.9) | 11 (11.6) | 0.143 |
| AHT (%) | 798 (47.1) | 714 (44.7) | 84 (88.4) | <0.001 |
| BMI (kg/m2) | 28.3 (±4.3) | 28.3 (±4.3) | 28.5 (±4.3) | 0.542 |
| SBP (mm Hg) | 146.6 (±20.2) | 147.1 (±20.2) | 138.5 (±18.3) | <0.001 |
| Prevalent diabetes (n (%)) | 683 (40.3) | 639 (40.0) | 44 (46.3) | 0.188 |
| Prevalent CVD (n (%)) | 185 (10.9) | 156 (9.8) | 29 (29.6) | <0.001 |
| Prevalent HF (n (%)) | 31 (1.8) | 16 (1.0) | 15 (15.8) | <0.001 |
Values are displayed as means (±SD) or, for skewed variables, medians and IQR (25–75).
AF, atrial fibrillation; AHT, antihypertensive treatment; BMI, body mass index; CVD, cardiovascular disease; HF, heart failure; SBP, systolic blood pressure.